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Abstract
Background: Whether intake of alpha-linolenic acid (ALA), the plant-derived n-3 polyunsaturated fatty acid (PUFA), could
prevent cardiovascular diseases is not yet clear. We examined the associations of ALA intake with 10-year incidence of
coronary heart disease (CHD) and stroke in the Netherlands.
Methods: Data were collected from a general population of 20,069 generally healthy men and women, aged 20 to 65 years.
Habitual diet was assessed at baseline (1993–1997) with a validated 178-item food frequency questionnaire. Incidences of
CHD and stroke were assessed through linkage with mortality and morbidity registers. Hazard ratios (HR) were calculated
with multivariable Cox proportional hazards models, adjusted for age, gender, lifestyle, and dietary factors.
Results: During 8–13 years of follow-up, we observed 280 incident CHD events (19% fatal) and 221 strokes (4% fatal). Intakes
of energy-adjusted ALA in quintiles ranged from less than 1.0 g/d in the bottom quintile (Q1) to more than 1.9 g/d in the
top quintile (Q5). ALA intake was not associated with incident CHD, with HRs varying between 0.89 and 1.01 (all p.0.05) in
Q2–Q5 compared with the bottom quintile of ALA intake. For incident stroke, however, participants in Q2–Q5 had a 35–50%
lower risk compared with the reference group. HRs were 0.65 (0.43–0.97), 0.49 (0.31–0.76), 0.53 (0.34–0.83), and 0.65 (0.41–
1.04) for Q2–Q5 respectively.
Conclusion: In this general Dutch population, ALA intake was not associated with incident CHD. The data suggested that a
low intake of ALA may be a risk factor for incident stroke. These results warrant confirmation in other population-based
studies and in trials.
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Introduction
Numerous studies suggest that marine n23 polyunsaturated
fatty acids (PUFA), mainly eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA), protect against cardiovascular
diseases (CVD) [1–3]. However, the role of the plant-derived
n23 PUFA alpha-linolenic acid (ALA) in CVD prevention is less
clear [4–6]. ALA is mainly found in vegetable oils such as soybean,
canola, and flaxseed oil, and walnuts [7].
In Western countries such as the Netherlands, the intake of
ALA is 5–10 times higher than n23 PUFA from fish [8]. ALA is
an essential fatty acid, which means that humans have to obtain it
through their diet. Humans can convert ALA into the very-long-
chain fatty acids EPA and DHA, although conversion only occurs
to a limited extent [9,10]. Apart from potential indirect effects of
ALA on CVD via conversion into EPA and DHA, it is suggested
that ALA could have direct anti-inflammatory [6,11], anti-
arrhythmic [12], anti-thrombotic [12] [13], or neuroprotective
effects [14]. However, others concluded that there was insufficient
evidence that ALA influences risk factors for CVD [15,16].
Several prospective cohort studies showed inverse associations of
ALA intake with fatal CVD [17], fatal coronary heart disease
(CHD) [17–19], sudden cardiac death [12], incident CHD [20],
incidentmyocardialinfarction(MI)[21],ornonfatalMI[20].Other
cohort studies suggested no protection of ALA intake against fatal
CVD [22], fatal CHD [12,21,23], sudden death [20], incident
CHD [23], or nonfatal MI [12,18]. The relation of ALA intake with
fatal CHD has been summarized in a meta-analysis of 5 prospective
cohort studies showing that ALA intakes of around 2 g/d were
associated with a 21% lower risk of fatal CHD (relative risk: 0.79;
95%CI, 0.60–1.04), compared with intakes of 0.8 g/d [24].
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17967Little is known about the association of ALA intake with stroke.
In a nested case-control study in 192 American middle-aged men,
serum ALA was inversely associated with stroke [25], although this
was not confirmed in a Japanese nested case-control study of with
197 cases of hemorrhagic and ischemic stroke [26]. However,
Japanese have higher mortality from stroke and have higher serum
levels of n23 PUFA compared with white Americans and
Europeans, which makes it difficult to compare the results [26].
We examined the 10-year incidence of CHD and stroke in
relation to ALA intake in a population-based cohort of over
20,000 adults in the Netherlands.
Methods
Ethical Statement
This research was performed in accordance with the ethical
principles for medical research involving human subjects outlined
in the Declaration of Helsinki. This research was approved by the
Medical Ethics Committee of TNO Prevention and Health
(Leiden, The Netherlands). All participants gave written informed
consent.
Design and study population
The ‘‘Monitoring Project on Risk Factors for Chronic Diseases’’
(MORGEN Study) is a Dutch population-based cohort of 22,654
men and women, aged 20 to 65 years. MORGEN is part of the
European Prospective Investigation into Cancer and Nutrition
(EPIC) study [27].
For the current study we excluded participants who did not
provide informed consent for vital status follow-up (n=701). We
also excluded 72 participants without dietary information and 97
participants with extreme energy intakes (,500 or .4,500 kcal for
women and ,800 or .5,000 kcal for men). Furthermore,
participants with a history of MI or stroke at baseline were
excluded (n=442). We also excluded participants who reported
use of lipid or blood pressure lowering medication (n=1,093) and
180 participants with diabetes resulting in 20,069 participants
(8,988 men and 11,081 women).
Dietary assessment
The habitual diet was assessed at baseline with the Dutch EPIC
Food Frequency Questionnaire (FFQ) a self-administered 178-
item FFQ covering the previous year [28,29]. The FFQ included
foods that covered the intake of foods and nutrients relevant to
chronic disease etiology for at least 90% of the national mean
intake. Participants indicated consumption of main food groups in
times per day, per week, per month, per year, or as never,
combined with questions on the relative intakes of foods within
food groups (seldom/never, sometimes, often, mostly/always). In
addition, we calculated raw vegetable consumption as the sum of
lettuce, cucumber, tomato, carrots, cabbage, sweet pepper, and
chicory consumption in grams per day, because these raw
vegetables are consumed together with salad dressings, which is
a main source of ALA.
Nutrient intakes were calculated with the ‘‘Dutch food
composition table’’ of 1998. For individual fatty acids, we used
the table of 2001. All nutrients were adjusted for total energy
intake with the residuals method [30]. The Dutch EPIC
questionnaire has been validated for several food groups and
nutrients. The reproducibility (estimated by 2 repeated measure-
ments) and the relative validity (intake assessed by the FFQ
compared to intakes assessed by 12 monthly 24-h recalls) of the
FFQ for various food groups and nutrients were assessed among
121 Dutch men and women [28,29]. The Spearman rank
correlations for the reproducibility of the FFQ after 6 months
were 0.90 and 0.80 for total energy and 0.83 and 0.77 for total fat
in men and women respectively. The relative validity of the FFQ
was 0.77 and 0.62 for total energy and 0.74 and 0.63 for total fat
in men and women respectively.
Mortality and morbidity
Vital status was checked through linkage with the national
population register. Participants were followed for the occurrence
of CVD by linkage with Statistics Netherlands for cause-specific
mortality and to the national hospital discharge register for
nonfatal events by a validated probabilistic linkage method
described in detail elsewhere [31]. Incident CHD included fatal
CHD (I20–I25), fatal and nonfatal cardiac arrest (I46), and
nonfatal MI (I21–I22) according to the International Classification
of Diseases (ICD-10, WHO). Incident stroke included fatal and
nonfatal cerebrovascular accidents and transient ischemic attacks
(I60–I66, G45). For hospital admissions, corresponding ICD9
codes were used. Both primary and secondary causes of death
were used for the classification of fatal events. For nonfatal events
we used the primary indication for hospital admission. Participants
were followed until death, incident CHD or stroke (first events
only), date of loss-to-follow-up (n=693) or 1 January 2006,
whichever came first.
Other baseline characteristics
Body weight, height, and blood pressure were measured by
trained research nurses. Levels of total cholesterol and high-
density lipoprotein cholesterol were assessed in plasma (non-
fasting) [32]. Questionnaires were used to assess presence of
diabetes, history of MI, history of stroke, medication use, parental
history of MI (MI of father before the age of 55 year or MI of
mother before the age of 65 years), educational level, and cigarette
smoking. Alcohol intake (assessed by FFQ) was categorized as no
intake, low to moderate intake (men#2 and women#1 glasses/d),
or high intake (men.2 and women.1 glasses/d). Physical activity
was assessed with a validated questionnaire in 76% of our cohort
(from 1994 onwards) [33]. For this subset, we calculated whether
participants were engaged in activities with a metabolic equivalent
score $4 (yes/no). Cycling (yes/no) and sports (yes/no) were
previously shown to be inversely related to CVD incidence in this
study population [34].
Statistical analysis
Participants’ characteristics by quintiles of energy-adjusted ALA
intake are presented as means with SD, medians with interquartile
ranges, or percentages. Correlations between the energy-adjusted
intakes of different types of fatty acids were assessed with the
Spearman rank correlation test.
We used Cox proportional hazards models to estimate relative
risks for the incidence of CHD, total stroke, and ischemic stroke
across quintiles of energy-adjusted ALA intake at baseline. For
hemorrhagic stroke we had insufficient cases. Hazard ratios (HR)
with 95% confidence intervals (CI) were obtained with the bottom
quintile of ALA intake as the reference category. The proportional
hazards assumption was tested and not rejected based on
Schoenfeld residuals and visual inspection.
In model 1, we adjusted for age and gender. In model 2, we
additionally adjusted for total energy intake (kJ/d), body mass
index (kg/m
2), alcohol intake (no, low to moderate, or high),
current cigarette smoking, high educational level (completed
higher vocational training or university), parental history of MI.
In model 3, we added energy-adjusted intakes of vitamin C (mg/
d), beta-carotene (mg/d), fiber (g/d), saturated fatty acids (g/d),
ALA, Coronary Heart Disease and Stroke
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1.
Quintiles of ALA intake, g/d
Q1 Q2 Q3 Q4 Q5
N 4,013 4,014 4,014 4,014 4,014
ALA, g/d 0.960.2 1.260.1 1.360.05 1.560.1 2.060.4
ALA, % of energy 0.460.05 0.460.03 0.560.02 0.660.04 0.860.1
ALA from dressings, g/d 0.160.1 0.360.1 0.360.2 0.460.2 0.760.5
ALA from other sources, g/d 0.860.2 0.960.1 1.060.2 1.160.2 1.360.4
Linoleic acid, g/d 11.164.3 12.563.2 13.463.0 14.663.1 17.264.2
Linoleic acid, % of energy 4.461.4 4.861.3 5.261.2 5.861.2 6.761.5
EPA+DHA,
2 mg/d 114 (61–194) 110 (60–192) 111 (58–189) 112 (61–194) 117 (65–198)
Male gender, % 59 41 38 40 46
Age, y 41.8611.7 42.0611.2 41.8611.0 41.3610.9 40.6610.6
Body mass index, kg/m
2 24.963.7 24.963.8 24.863.8 24.863.8 24.964.1
Polyunsaturated fatty acids, g/d 13.964.40 15.963.2 17.063.0 18.463.1 21.664.3
Polyunsaturated fatty acids, % of energy 5.661.5 6.161.3 6.661.2 7.361.2 8.461.5
Cis-monounsaturated fatty acids, g/d 27.565.9 30.064.7 31.164.6 32.064.7 34.065.8
Cis-monounsaturated fatty acids, % of energy 10.962.0 11.561.9 12.061.9 12.561.9 13.362.0
Trans fatty acids, g/d 3.461.5 3.761.2 3.861.1 3.961.2 4.161.5
Trans fatty acids, % of energy 1.460.5 1.460.5 1.560.5 1.560.5 1.660.5
Saturated fatty acids, g/d 35.167.8 36.766.1 37.365.8 37.765.8 38.366.4
Saturated fatty acids, % of energy 13.862.7 14.262.5 14.462.4 14.662.4 14.962.4
Carbohydrate, % of energy 45.466.3 44.565.8 43.565.4 42.765.2 41.365.1
Protein, % of energy 15.062.4 15.562.3 15.362.2 15.262.1 14.462.0
Vitamin C,
2 mg/d 103 (77–138) 101 (77–132) 99 (77–129) 98 (75–127) 93 (70–124)
Beta carotene, mg/d
{ 1.4 (1.1–1.7) 1.4 (1.1–1.8) 1.4 (1.2–1.8) 1.5 (1.2–1.9) 1.5 (1.2–2.0)
Fiber, g/d 24.366.0 24.765.1 24.764.8 24.864.9 24.565.4
Energy intake, MJ/d 10.662.9 9.062.5 8.862.5 9.162.6 10.162.9
Current smoking, % 34 33 35 38 44
Alcohol consumption, %
No 12 13 12 12 13
Low to moderate 50 58 58 61 58
High 38 29 30 27 29
Highly educated,
3 % 2 4 2 52 72 52 4
Dutch ethnicity, % 97 97 97 96 95
Physically active,
4 %
Engaged in cycling 59 61 60 59 57
Engaged in sports 39 40 38 35 34
Parental history of myocardial infarction, % 8 9 9 10 9
Plasma total cholesterol,
5 mmol/l 5.361.1 5.361.0 5.361.1 5.361.1 5.261.0
Plasma HDL-cholesterol,
5 mmol/l 1.360.4 1.460.4 1.460.4 1.460.4 1.360.4
Systolic blood pressure, mm Hg 122.0615.7 120.1615.9 119.5615.5 119.0615.1 119.0615.3
Diastolic blood pressure, mm Hg 77.0610.4 76.2610.4 76.0610.5 75.7610.2 75.6610.3
Footnotes Table 1.
ALA: alpha-linolenic acid; Q1–Q5: quintiles; EPA: eicosapentaenoic acid; DHA: docosahexaenoic acid.
1Values are means 6 SD, unless indicated otherwise.
2Median with interquartile range.
3University or higher vocational training.
4Available for participants enrolled between 1994 and 1997 (n=15,423).
5Nonfasting.
doi:10.1371/journal.pone.0017967.t001
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ALA (g/d).
Possible confounding by physical activity was checked in the
subgroup of participants with information on physical activity. We
examined whether further adjustment for systolic blood pressure
and total cholesterol changed the association of ALA with CHD
and stroke to assess whether these factors could be intermediates.
Effect modification was evaluated for age and gender. In various
foods ALA is highly correlated with saturated fatty acids and trans
fatty acids. We therefore separately analyzed ALA intake from
salad dressings (mayonnaise+soy bean oil), with a low content of
saturated fatty acids and trans fatty acids vs. ALA intake from
other sources, mutually adjusted. These analyses were additionally
adjusted for the intake of raw vegetables. All statistical analyses
were performed with SAS (version 9.1; SAS Institute). Two-sided
p-values,0.05 were considered statistically significant.
Results
Population characteristics
Participants were on average 6 SD 41.5611.1 years at
baseline, and 45% were male. Men had higher ALA intakes than
women (1.660.6 vs. 1.260.5 g), but values were similar after
energy adjustment (1.460.4 g). During 8–13 years of follow-up
(median 10.5 y), 280 CHD events (19% fatal) and 221 strokes (4%
fatal) occurred. Total stroke comprised 80 cases of ischemic
cerebrovascular accident (36%), 59 transient ischemic attacks
Table 2. Associations of incident coronary heart disease and stroke by quintiles of energy-adjusted ALA intake in 20,069 Dutch
men and women
1.
Quintiles of ALA intake, g/d
Q1 Q2 Q3 Q4 Q5
N 4,013 4,014 4,014 4,014 4,014
Median ALA, g/d 1.0 1.2 1.3 1.5 1.9
Coronary heart disease
N o . e v e n t s 6 85 14 75 36 1
Model 1
2 1.0 (ref) 0.90 (0.63–1.30) 0.87 (0.60–1.27) 1.01 (0.70–1.44) 1.16 (0.82–1.64)
Model 2
3 1.0 (ref) 0.89 (0.61–1.29) 0.89 (0.61–1.30) 0.97 (0.67–1.40) 1.03 (0.72–1.46)
Model 3
4 1.0 (ref) 0.89 (0.61–1.30) 0.90 (0.61–1.33) 0.97 (0.66–1.44) 1.01 (0.66–1.54)
Total stroke
N o . e v e n t s 6 44 33 43 54 5
Model 1
2 1.0 (ref) 0.71 (0.48–1.04) 0.57 (0.38–0.87) 0.62 (0.41–0.93) 0.83 (0.57–1.22)
Model 2
3 1.0 (ref) 0.68 (0.46–1.01) 0.53 (0.34–0.81) 0.59 (0.39–0.90) 0.78 (0.53–1.15)
Model 3
4 1.0 (ref) 0.65 (0.43–0.97) 0.49 (0.31–0.76) 0.53 (0.34–0.83) 0.65 (0.41–1.04)
Ischemic stroke
N o . e v e n t s 4 52 72 12 32 8
Model 1
2 1.0 (ref) 0.65 (0.40–1.05) 0.52 (0.31–0.87) 0.59 (0.36–0.98) 0.74 (0.46–1.20)
Model 2
3 1.0 (ref) 0.63 (0.39–1.02) 0.45 (0.26–0.77) 0.55 (0.33–0.92) 0.70 (0.43–1.12)
Model 3
4 1.0 (ref) 0.63 (0.38–1.04) 0.45 (0.26–0.79) 0.56 (0.32–0.97) 0.70 (0.39–1.26)
Footnotes Table 2.
ALA: alpha-linolenic acid; Q1–Q5: quintiles.
1Values are hazard ratios (95% CI), with the first quintile as the reference category.
2Model 1: adjusted for age and gender (n=20,069).
3Model 2: model 1 with additional adjustments for body mass index, total energy intake, cigarette smoking, educational level, parental history of myocardial infarction,
alcohol intake (n=19,896).
4Model 3: model 2 with additional adjustments for intake of vitamin C, beta-carotene, fiber, saturated fatty acids, trans fatty acids, polyunsaturated fatty acids other than
ALA (n=19,896).
doi:10.1371/journal.pone.0017967.t002
Figure 1. The association of incident total stroke by quintiles of
energy-adjusted ALA intake
1,2.
1 Hazard ratios (95% CI) with the
first quintile as the reference category, adjusted for age, gender, body
mass index total energy intake, alcohol intake, cigarette smoking,
education level, parental history of myocardial infarction, intake of
vitamin C, beta-carotene, fiber, saturated fatty acids, trans fatty acids,
polyunsaturated fatty acids other than ALA.
2 ALA: alpha-linolenic acid;
Q1–Q5: quintiles.
doi:10.1371/journal.pone.0017967.g001
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unspecified stroke (16%).
The main sources of ALA intake were mayonnaise (15%),
margarine (14%), soy bean oil (8%), and bread (8%). Median
energy-adjusted ALA intakes in quintiles ranged from less than
1.0 g/d to more than 1.9 g/d. ALA intake was positively
associated with intakes of total PUFA (mainly linoleic acid), cis-
monounsaturated fat, trans fatty acids, and saturated fatty acids,
but not with EPA+DHA (Table 1). The Spearman rank
correlations with ALA were 0.54 for linoleic acid, 0.41 for cis-
monounsaturated fatty acids, 0.22 for trans fatty acids, and 0.18
for saturated fatty acids.
ALA intake and incident CHD and stroke
After adjustment for potential confounders, ALA intake was not
associated with incident CHD. HRs varied between 0.89 and 1.01
(all p.0.05) compared with the bottom quintile of ALA intake
(Table 2). ALA intake was inversely associated with total stroke
(Figure 1) and ischemic stroke incidence. Compared with the lowest
quintileofALAintake(,1.1 g/d),participantsinthe otherquintiles
had a 35–50% lower risk of incident total stroke and ischemic
stroke. The lowest risks were observed in quintiles 3 and 4.
Median energy-adjusted intakes of ALA from salad dressings
increased from 0.1 g/d to 0.7 g/d across quintiles. ALA from
other sources (mainly margarines) increased from 0.7 to 1.4 g/d.
Incident CHD was not associated with ALA from salad dressings
(Table 3) or with ALA from other sources (Table 4). The inverse
association of ALA intake with total and ischemic stroke was
stronger for ALA from salad dressings compared with total ALA,
while ALA from other sources was not associated with stroke.
Compared with the bottom quintile of ALA intake, participants in
the higher quintiles had an 18–61% lower risk of total stroke and a
25–58% lower risk of ischemic stroke. The inverse associations
were most pronounced in quintiles 3 and 4. After additional
adjustment for raw vegetable consumption, the associations were
somewhat weaker, but remained statistically significant, except for
the top quintile of ALA.
The associations of ALA intake with incident CHD and stroke
did not differ in subgroups of age and gender. For the subgroup
Table 3. Associations of incident coronary heart disease and stroke by quintiles of energy-adjusted ALA intake from salad
dressings in 20,069 Dutch men and women
1.
Quintiles of ALA intake
Q1 Q2 Q3 Q4 Q5
N 4,013 4,014 4,014 4,014 4,014
Median ALA in salad
dressings,
2 g/d
0.1 0.2 0.3 0.5 0.7
Median ALA in other
sources, g/d
1.0 1.0 1.0 1.0 0.9
Coronary heart disease
N o . e v e n t s 7 85 65 54 24 9
Model 1
3 1.0 (ref) 0.93 (0.66–1.32) 1.07 (0.75–1.51) 0.90 (0.62–1.32) 1.20 (0.83–1.73)
Model 2
4 1.0 (ref) 0.93 (0.66–1.32) 1.02 (0.71–1.45) 0.83 (0.56–1.23) 1.06 (0.73–1.54)
Model 3
5 1.0 (ref) 0.95 (0.67–1.34) 1.04 (0.72–1.49) 0.86 (0.58–1.29) 1.14 (0.76–1.70)
Model 4
6 1.0 (ref) 0.94 (0.66–1.34) 1.03 (0.71–1.49) 0.85 (0.56–1.30) 1.12 (0.72–1.75)
Total stroke
N o . e v e n t s 7 86 02 82 62 9
Model 1
3 1.0 (ref) 0.85 (0.60–1.19) 0.45 (0.29–0.69) 0.44 (0.28–0.70) 0.55 (0.36–0.86)
Model 2
4 1.0 (ref) 0.83 (0.59–1.18) 0.44 (0.28–0.68) 0.41 (0.26–0.66) 0.52 (0.33–0.81)
Model 3
5 1.0 (ref) 0.82 (0.57–1.16) 0.42 (0.27–0.66) 0.39 (0.24–0.62) 0.46 (0.28–0.74)
Model 4
6 1.0 (ref) 0.85 (0.59–1.20) 0.45 (0.29–0.72) 0.44 (0.27–0.72) 0.57 (0.34–0.96)
Ischemic stroke
N o . e v e n t s 5 43 72 01 71 6
Model 1
3 1.0 (ref) 0.77 (0.50–1.17) 0.47 (0.28–0.79) 0.43 (0.24–0.74) 0.44 (0.25–0.78)
Model 2
4 1.0 (ref) 0.74 (0.48–1.15) 0.45 (0.27–0.77) 0.40 (0.23–0.71) 0.41 (0.23–0.73)
Model 3
5 1.0 (ref) 0.75 (0.48–1.16) 0.46 (0.27–0.79) 0.42 (0.23–0.74) 0.42 (0.23–0.79)
Model 4
6 1.0 (ref) 0.78 (0.50–1.21) 0.50 (0.29–0.86) 0.47 (0.26–0.86) 0.51 (0.26–1.02)
Footnotes Table 3.
ALA: alpha-linolenic acid; Q1–Q5: quintiles.
1Values are hazard ratios (95% CI), with the first quintile as the reference category.
2Analyses on ALA in salad dressings are adjusted for ALA in other sources in all models.
3Model 1: adjusted for age and gender (n=20,069).
4Model 2: model 1 with additional adjustments for body mass index, total energy intake, cigarette smoking, educational level, parental history of myocardial infarction,
alcohol intake (n=19,896).
5Model 3: model 2 with additional adjustments for intake of vitamin C, beta-carotene, fiber, saturated fatty acids, trans fatty acids, polyunsaturated fatty acids other than
ALA (n=19,896).
6Model 4: model 3 with additional adjustment for raw vegetables (n=19,896).
doi:10.1371/journal.pone.0017967.t003
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with and without physical activity yielded similar results.
Adjustment for plasma cholesterol or systolic blood pressure did
not change the results. HRs (95%CI) for total stroke after
additional inclusion of systolic blood pressure were 0.66 (0.44–
0.98), 0.50 (0.32–0.78), 0.54 (0.34–0.84) and 0.67 (0.42–1.06) for
Q2–Q5 compared with Q1, respectively.
Discussion
In this large prospective cohort study in the Netherlands, we
found no association between ALA intake and incident CHD.
However, ALA intakes .1.1 g/d were associated with a 35–50%
lower risk of incident stroke, mainly ischemic stroke, compared
with ALA intakes ,1.1 g/d.
This study has several strengths, including almost complete
mortality follow up and detailed information on potential
confounders. Nonfatal cardiovascular events were assessed
through the national hospital discharge register. In part of the
subjects included in our analysis, hospital discharge diagnoses for
MI were validated by comparison with the clinical registry of the
Cardiology Department of the Maastricht University Hospital,
showing a relatively high sensitivity (84%) and positive predictive
value (97%) for MI [35]. We assume that misclassification of stroke
was limited, because brain imaging is used to identify stroke and its
subtypes in 98% of the patients admitted to Dutch hospitals [36].
However, there were also limitations. First, misclassification of
participants for ALA intake may have occurred. However, because
we excluded participants with a history of MI or stroke, and
participants who used cholesterol lowering or blood pressure
lowering medication, we expect misclassification at baseline to be
random rather than dependent on disease outcome. Second,
hospital discharge diagnoses were assessed through probabilistic
linkage with the national hospital discharge register. If we have
missed events by this procedure, then this is unlikely to be related
to ALA intake and may have caused bias towards the null.
In our study, ALA intakes in the range of 1.0–1.9 g/d were not
associated with incident CHD. This is in line with a cohort study
in elderly Dutch men (Zutphen Study), which did not show a
benefit of ALA intake on incident CHD, for similar levels of intake
Table 4. Associations of incident CHD and stroke by quintiles of energy-adjusted ALA intake from other sources than salad
dressings in 20,069 Dutch men and women
1.
Quintiles of ALA intake
Q1 Q2 Q3 Q4 Q5
N 4,013 4,014 4,014 4,014 4,014
Median ALA in other
sources,
2 g/d
0.7 0.9 1.0 1.1 1.4
Median ALA in salad
dressings,
2 g/d
0.3 0.3 0.3 0.3 0.3
Coronary heart disease
No. events 66 42 46 54 72
Model 1
3 1.0 (ref) 0.72 (0.49–1.06) 0.81 (0.55–1.19) 0.87 (0.61–1.25) 0.96 (0.68–1.34)
Model 2
4 1.0 (ref) 0.73 (0.49–1.10) 0.81 (0.54–1.22) 0.88 (0.61–1.29) 0.91 (0.64–1.29)
Model 3
5 1.0 (ref) 0.73 (0.48–1.10) 0.80 (0.53–1.22) 0.85 (0.57–1.28) 0.85 (0.56–1.27)
Model 4
6 1.0 (ref) 0.73 (0.48–1.10) 0.80 (0.53–1.22) 0.85 (0.57–1.28) 0.84 (0.56–1.27)
Total stroke
No. events 41 38 38 45 59
Model 1
2 1.0 (ref) 0.87 (0.56–1.36) 0.85 (0.54–1.33) 0.96 (0.62–1.47) 1.12 (0.75–1.67)
Model 2
3 1.0 (ref) 0.91 (0.58–1.45) 0.88 (0.55–1.40) 0.97 (0.62–1.52) 1.10 (0.72–1.66)
Model 3
4 1.0 (ref) 0.88 (0.55–1.41) 0.83 (0.51–1.35) 0.92 (0.57–1.48) 0.96 (0.59–1.56)
Model 4
5 1.0 (ref) 0.88 (0.55–1.41) 0.82 (0.51–1.34) 0.89 (0.56–1.44) 0.93 (0.57–1.51)
Ischemic stroke
No. events 29 26 22 26 41
Model 1
3 1.0 (ref) 0.86 (0.51–1.47) 0.72 (0.41–1.26) 0.80 (0.47–1.36) 1.09 (0.68–1.77)
Model 2
4 1.0 (ref) 0.85 (0.49–1.47) 0.69 (0.38–1.23) 0.77 (0.44–1.33) 1.02 (0.62–1.68)
Model 3
5 1.0 (ref) 0.85 (0.49–1.50) 0.69 (0.38–1.27) 0.77 (0.42–1.39) 1.01 (0.56–1.83)
Model 4
6 1.0 (ref) 0.85 (0.48–1.49) 0.68 (0.37–1.25) 0.75 (0.41–1.36) 0.98 (0.54–1.78)
Footnotes Table 4.
ALA: alpha-linolenic acid; Q1–Q5: quintiles.
1Values are hazard ratios (95% CI), with the first quintile as the reference category.
2Analyses on ALA from other sources than salad dressings are adjusted for ALA in salad dressings in all models.
3Model 1: adjusted for age and gender (n=20,069).
4Model 2: model 1 with additional adjustments for body mass index, total energy intake, cigarette smoking, educational level, parental history of myocardial infarction,
alcohol intake (n=19,896).
5Model 3: model 2 with additional adjustments for intake of vitamin C, beta-carotene, fiber, saturated fatty acids, trans fatty acids, polyunsaturated fatty acids other than
ALA (n=19,896).
6Model 4: model 3 with additional adjustment for raw vegetables (n=19,896).
doi:10.1371/journal.pone.0017967.t004
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between the top and bottom quintile of ALA intake, ALA intake
was inversely associated with fatal CHD, but not with nonfatal MI
[12,18]. Our results on CHD differ from those of the Health
Professionals Follow-up Study, in which an increase of one energy
percent of linolenic acid (mainly ALA) intake was associated with a
60% lower risk of incident MI in men [21]. These results were not
adjusted for other PUFA, saturated fatty acids, or trans fatty acids,
and the contrast between the top and bottom quintile of ALA
intake was only 0.7 g/d (,0.3 energy percent). A later study of this
cohort with additional adjustment for other fatty acids suggested a
16% lower risk for total CHD (borderline significant) correspond-
ing with an increase of ALA of 1g/d [20]. Our results also differ
from a large case-control study in Costa Rica, which supported an
inverse association of ALA intake with nonfatal MI, with an odds
ratio (95% CI) of 0.61 (0.42–0.80) for the top (2.4g/d) vs. the
bottom (1.1g/d) decile of ALA intake [13]. Similar, but stronger,
associations were observed for ALA status in adipose tissue in the
same study. No further risk reductions were obtained beyond the
7th decile of ALA status, corresponding to an ALA intake of
1.8 g/d [13]. Although this retrospective study suggested that
benefits of ALA on CHD could already be achieved at modest
levels [13,37], our prospective study did not support this.
Misclassification of ALA intake, especially within a relatively
narrow range of intake, may have attenuated our associations.
ALA intake levels in the Netherlands are comparable to most West
European countries and the United States of America [38]. Within
the range of ALA intake that we studied, the associations with
CHD and stroke can therefore be extrapolated to other western
populations.
Despite the small range of intake in our study, we did find an
inverse association of ALA intake with incident stroke, which was
most pronounced for ALA from salad dressings. It is not likely that
ALA from different food sources would act differently. Although
we adjusted for many potential confounders, including the intake
of raw vegetables, the associations may still be influenced by a
healthier diet and lifestyle of those who regularly eat raw
vegetables with salad dressings. In general, correlated fatty acids
in foods and residual confounding play an important role in cohort
studies and results should therefore be judged with caution.
Epidemiological studies of ALA intake or status and stroke are
scanty. Our results are in line with a nested case-control study in
middle-aged American men at high risk for CVD [25]. In that
study, one SD increase of ALA in serum cholesteryl esters was
associated with a 37% decrease in risk of stroke.
Humans can convert ALA into the longer-chain fatty acid EPA
and eventually DHA, although conversion occurs to a limited
extent [39]. Apart from potential indirect effects of ALA on CVD
via conversion into EPA and DHA, ALA has been suggested to
have anti-inflammatory [6,11], anti-arrhythmic [12], anti-throm-
botic [12,13], or neuroprotective effects [14]. However, others
concluded that there was insufficient evidence that ALA influences
risk factors for CVD [15,16]. Although CHD and ischemic stroke
are both atherosclerotic disorders that have risk factors in
common, we found differential associations of ALA intake for
CHD and stroke. A proposed mechanism from animals studies for
a protective effect of ALA on incident ischemic stroke is that ALA
would be neuroprotective after induced ischemia, by beneficially
affecting the brain blood flow [14].
Concluding, in this generally healthy Dutch population, ALA
intake was not associated with incident CHD. However, the data
suggested that a low intake of ALA may be a risk factor for
incident stroke, although more prospective studies are needed
before definite conclusions can be drawn.
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